Zydus Pharmaceuticals (USA) Inc recalls Venlafaxine Tablets
- Published
- 16 Apr 2025
- Units affected
- 13,128 100-Count Bottles
- Agency
- FDA
- Country
- United States
The hazard
Presence of Foreign Substance: Product complaint received for the presence of foreign material embedded resembling a metal shaving in one tablet.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.
- Check the lot number on the box or bottle.
- Talk to your pharmacist or doctor before stopping any prescribed medicine.
- Return the product to the pharmacy for safe disposal.
Product details
Venlafaxine Tablets, USP, 75 mg, 100 Tablets, Rx only, Mfg. by: Zydus Lifesciences Ltd, Ahmedabad, India, Dist. by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-021-01.
- Brand / company
- Zydus Pharmaceuticals (USA) Inc
- Codes / lots
- Lot #: M314265, Exp.: 31 October 2025.
- Distribution
- US Nationwide.
- Recall status
- Completed
Source: U.S. Food and Drug Administration, published 16 Apr 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.